Elite members get real-time data, technical charting, alerts, and no ads - starting at $24.96/mo.
Try Elite for Free
Last Close
0.1833
Oct 23 • 4:00 PM ET Dollar change-0.0007 Percentage change(-0.38%)
Aftermarket Close
0.1900
Aftermarket • 7:59 PM ET Dollar change+0.0067 Percentage change(3.66%)
Index
-
Market Cap
17.49M
Enterprise Value
104.13M
Income
-37.34M
Sales
111.57M
Book/sh
-0.59
Cash/sh
0.20
Dividend Est.
-
Dividend TTM
-
Dividend Ex-Date
-
Dividend Gr. 3/5Y
- -
Payout
-
Employees
364
IPO
Nov 04, 2021
P/E
-
Forward P/E
-
PEG
-
P/S
0.16
P/B
-
P/C
0.91
P/FCF
-
EV/EBITDA
-
EV/Sales
0.93
Quick Ratio
0.98
Current Ratio
1.15
Debt/Eq
-
LT Debt/Eq
-
Option/Short
No / Yes
EPS (ttm)
-0.73
EPS next Y
-0.28
EPS next Q
-0.09
EPS this Y
24.38%
EPS next Y
44.08%
EPS next 5Y
40.66%
EPS past 3/5Y
37.71% 27.91%
Sales past 3/5Y
42.79% 42.48%
EPS Y/Y TTM
16.23%
Sales Y/Y TTM
12.75%
EPS Q/Q
-50.77%
Sales Q/Q
2.27%
Insider Own
31.90%
Insider Trans
7.80%
Inst Own
37.04%
Inst Trans
49.71%
ROA
-25.87%
ROE
-2440.41%
ROIC
-50.70%
Gross Margin
59.15%
Oper. Margin
-19.01%
Profit Margin
-33.46%
SMA20
-61.13%
SMA50
-69.97%
SMA200
-88.59%
Trades
Shs Outstand
95.42M
Shs Float
64.98M
52W High
5.33 -96.56%
52W Low
0.17 7.19%
Volatility
17.93% 15.63%
ATR (14)
0.06
RSI (14)
22.47
Beta
0.76
Rel Volume
0.11
Avg Volume
6.04M
Volume
656,464
Perf Week
-11.28%
Perf Month
-68.51%
Perf Quarter
-56.15%
Perf Half Y
-91.19%
Perf YTD
-94.87%
Perf Year
-95.83%
Perf 3Y
-92.30%
Perf 5Y
-
Perf 10Y
-
Prev Close
0.18
Price
0.18
Change %
-0.38%
Date Action Analyst Rating Change Price Target Change
Oct-19-26Downgrade BTIG Research Buy → Neutral
Oct-16-26Downgrade Lake Street Buy → Hold $0.50
Oct-16-26Downgrade Craig Hallum Buy → Hold
May-14-26Downgrade William Blair Outperform → Mkt Perform
Jul-17-25Initiated Craig Hallum Buy $8
Oct-31-24Initiated Lake Street Buy $7
May-31-23Initiated TD Cowen Outperform $7
Jul-18-22Resumed Oppenheimer Outperform $18
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Bleichroeder LP10% OwnerSep 17 '26Proposed Sale0.701,500,0001,056,900Sep 17 05:42 PM
MVM Partners, LLCDirectorAug 13 '26Buy0.452,202,6431,000,0006,903,100Aug 17 04:05 PM
MDxHealth SA is a commercial-stage precision diagnostics company, which engages in the development and commercialization of molecular diagnostic products for personalized cancer treatment. It operates through the following geographical segments: United States of America, Europe and Rest of the World. The firm offers ConfirmMDx, SelectMDx, AssureMDx, InformMDx, SelectMDx, and MonitorMDx. The company was founded by Herman Spolders and Philip S. Devine on January 10, 2003 and is headquartered in Herstal, Belgium.
CEO & Executive DirectorMr. Michael K. McGarrity
Interim Chief Financial OfficerMr. Ron Kalfus CPA
LLMMr. Joseph Sollee J.D.
Chief Commercial OfficerMr. John A. Bellano
Vice President of Finance & AccountingMr. Scott McMahan